Ovarian Cancer: Another Promising Target for Liquid Biopsy
A blood test to screen for ovarian cancer is one of many new liquid biopsy assays being evaluated to screen for cancer.
Source: medscape.com
Delfi Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Delfi Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Delfi Diagnostics Today - Breaking & Trending Today
City of Hope and DELFI Diagnostics announce collaboration to improve lung cancer screening rates in underserved areas of Los Angeles
/PRNewswire/ -- City of Hope, one of the largest cancer research and treatment organizations in the United States, and DELFI Diagnostics, Inc., a developer of...
Source: prnewswire.com
DELFI Diagnostics Supports Proposed Legislation to Allow CMS to Review New Blood-Based Screening Tests for Lung Cancer
/PRNewswire-PRWeb/ -- DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to enhance cancer detection, today announced...
Source: prnewswire.com
Cancer Biopsy Market Surpass $67.11 billion by 2030 - Exclusive Report by Coherent Market Insights
/PRNewswire/ -- According to Coherent Market Insights, The global cancer biopsy market was valued at US$ 25.61Billion in 2023 and is forecast to reach a value...
Source: prnewswire.com
Liquid biopsies could be used as an early marker of immunotherapy response, study finds
Liquid biopsies are blood tests that can serially measure circulating tumor DNA (cell-free DNA that is shed into the bloodstream by dying cancer cells).
Source: news-medical.net